Target intelligence / Profile preview

CNNM3 divergent transcript (CNNM3-DT)

Target
CNNM3-DT
Molecular classification
Long non-coding RNA, Other
01

Overview

CNNM3 divergent transcript (CNNM3-DT; LOC100506036) is a long non-coding RNA gene transcribed from a locus divergent to the protein-coding CNNM3 gene on human chromosome 2 (2q11.2)[3][1]. Like other genes named with the "-DT" suffix, it is a non-coding RNA transcribed in the opposite direction of its protein-coding neighbor[7]. There is currently no evidence that CNNM3-DT encodes a protein product or acts as a therapeutic target, receptor, enzyme, transporter, or known cell surface molecule. Its function, clinical relevance, and roles in disease remain uncharacterized in the scientific literature. If you are seeking information on the CNNM3 protein (Metal transporter CNNM3, Cyclin M3), it is a magnesium transporter with proposed roles in magnesium homeostasis and cancer[2][4][6]; however, CNNM3-DT is a distinct non-coding transcript and not the protein itself.

Other names
LOC100506036
02

Biological functions

Not established; predicted to function as a non-coding RNA, general lncRNA regulatory roles possible
03

Disease associations

None established; no evidence for disease association as a target

Beyond the preview

Go deeper on CNNM3 divergent transcript (CNNM3-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CNNM3 divergent transcript (CNNM3-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call